Celeste Orr and Erin Leigh Courtice respond to criticisms of the British Medical Associations’ guide on inclusive language which aims to ensure that trans, intersex, genderqueer, and non-binary people are not subjected to discriminatory language.
Teresa Blankmeyer Burke considers the problematic nature of gene therapy research aimed at eliminating hereditary deafness.
Andrew Mitchell suggests that innovative institutional changes are needed to sustain universal healthcare in Canada.
Françoise Baylis wonders how it is that in 14 months (from December 2015 to February 2017), the U.S. National Academy of Sciences and the U.S. National Academy of Medicine have moved human germline genome editing out of the category ‘irresponsible’ and into the category ‘permissible.’
Impact Ethics 